Boston Scientific Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 3,856 million compared to USD 3,389 million a year ago. Net income was USD 495 million compared to USD 314 million a year ago.

Basic earnings per share from continuing operations was USD 0.34 compared to USD 0.21 a year ago. Diluted earnings per share from continuing operations was USD 0.33 compared to USD 0.21 a year ago.